Prediction of therapy response based on RECIST criteria only has limitations for the immunotherapy era! Longitudinal assessment of simple inflammatory 🔥blood biomarkers (CRP + albumin integrated into modified Glasgow Prognostic Score/ mGPS) provides complementary information

Great start of #EAU24 catching up with friends and colleges. Congrats 👏🏼 to EAU team for smooth start and all hard work European Association of Urology (EAU) OncoAlert UroToday.com Arnulf Stenzl Maria J. Ribal James N'Dow Morgan Roupret

Fantastic start of #APCCC perfect also in virtual format for the ones that couldn’t make it to #Lugano #Apccc24 Advanced Prostate Cancer Consensus Conference silke gillessen aurelius omlin OncoAlert Thomas Zilli Derya Tilki, MD Daniel Castellano Rana McKay, MD, FASCO Piet Ost Dra. María Natalia Gandur Quiroga Deborah Mukherji Neeraj Agarwal, MD, FASCO Ravindran Kanesvaran

Out now! "Targeted Investigational Treatment Analysis of Novel Anti‐androgen (TITAN) study: ultralow prostate‐specific antigen decline with apalutamide plus androgen‐deprivation therapy" BJU International Simon C Neeraj Agarwal, MD, FASCO Sabine D. Brookman-May Anders Bjartell bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj…

Honored to share my Urologist’s perspective at ESMO-SIOG: Working together in the era of personalized care for older adults with cancer session Join us on Monday, 16 Sep 2024 - 08:30 - 10:00 Toledo Auditorium - Hall 3 ESMO - Eur. Oncology OncoAlert #ESMO24 Ravindran Kanesvaran #mHSPC

OS benefit 👍 for TALAPRO-2 study of PARPi Talazoparib +Enza vs. Enza in metastatic castrate-resistant prostate cancer Neeraj Agarwal, MD, FASCO OncoAlert European Association of Urology (EAU) #DGHO24 businesswire.com/news/home/2024…’s-TALZENNA®-in-Combination-with-XTANDI®-Prolongs-Overall-Survival-in-Phase-3-TALAPRO-2-Trial

Honored to present #AVENGER study results #EMUC24 - full story just submitted for publication European Urology Advances in Therapy European Association of Urology (EAU) Universitätsklinikum Schleswig-Holstein Carsten Ohlmann

Just in 👉 BJU International in this post hoc analysis of TITAN we show, that patients with the deepest PSA decline derived the greatest benefit in #mHSPC #ProstateCancer Link: bjui-journals.onlinelibrary.wiley.com/doi/epdf/10.11… UroToday.com OncoAlert European Association of Urology (EAU)

Medtronic Hugo RAS is one of the newest robotic system for minimal invasive surgery. We are honored to join the live surgery session #Hugo robotic assisted partial nephrectomy at German robotic annual meeting #Straubingen 👏🏼 Prof. Dr. Daniar Osmonov, FECSM 💪 #DRUS #DRUS2024 #livestream Universitätsklinikum Schleswig-Holstein

A great Pleasure to Present our paper on Management of patients with Advanced #ProstateCancer : A Report from #APCCC24 LINK TO ARTICLE👇👇👇👇👇👇👇👇 sciencedirect.com/science/articl… NOW ON FINAL SESSION of #PROSCA24 The 2024 Advanced Prostate Cancer Consensus Conference (APCCC)

📹 Watch this roundtable discussion with a multi-disciplinary panel moderated by Prof. Axel S. Merseburger . They review a difficult metastatic case involving a 72-year-old with biochemical recurrence, oligometastatic disease. Learn more here 👇 prostate.uroonco.uroweb.org/video/round-ta…

#UroUpdate 2025 - Berlin 07.-08. Februar 2025 - safe the Date! #Berlin #Urologie #UroUpdate25 BvDUrologie GeSRU Christian Wülfing Julian Struck Hannah Arnold Axel S. Merseburger Christian Gratzke UroFors @martin_schostak Pia Paffenholz Anmeldung unter: uro-update.com

First #ASCOGU25 #GU25 voting: When would you consider HR clinically meaningful in HRR allcomer population OncoAlert Neeraj Agarwal, MD, FASCO Yüksel Ürün Christian Gratzke UroUpdate Sumanta K. Pal, MD, FASCO Marc-Oliver Grimm Declan Murphy Toni Choueiri, MD Matt Cooperberg Brian F. Chapin Todd 〽️ Morgan, MD Alicia Morgans, MD, MPH Sabine D. Brookman-May

🚀 Who are the top oncologists leading the digital conversation? 📢 Check out this ranking of digital thought leaders in oncology based on their Twitter following! 📊 Notably, female oncologists highlighted in green! 👇 #MedTwitter #GU25 #ASCOGU25 ONCO BRUNO OncoAlert

Looking forward meeting Boris Hadaschik Ken Herrmann Marc-Oliver Grimm erikbelleville at poster L27 "Prostate Cancer Real World Evidence Registry (PROCARE): Recurrent and metastatic prostate cancer" Study aims to enroll 5,000 patients in Germany #GU25 #ASCOGU25 #mHSPC #mCRPC OncoAlert

⚡️PCa Oral Abstract Session⚡️ Final OS w/ TALA + ENZA as 1L Tx in unselected pts with mCRPC in the Ph 3 TALAPRO-2 trial Neeraj Agarwal, MD, FASCO UroToday.com #medicalavatar #prostatecancer #GU25 medudy Dra. María Natalia Gandur Quiroga Bárbara Melão, MD, PhD Todd 〽️ Morgan, MD Yüksel Ürün Alison Tree 💙 Alicia Morgans, MD, MPH

Honored to be mentioned by my mentor Prof. Vinata Lokeshwar in her great article on: "Natural history of bladder cancer: Validation of the multiple pathway ..." OncoAlert European Association of Urology (EAU) Universitätsklinikum Schleswig-Holstein sciencedirect.com/science/articl…

🚨 TODAY! Get the latest updates on mHSPC! 🏥 Dive into novel treatment strategies, strengthen MDT collaboration, and refine care pathways for better patient outcomes. 🎯 Don't miss out! 🔗 Learn more: ms.spr.ly/6013qRltx #mHSPC Axel S. Merseburger Alberto Bossi Elena Castro

🌟The future of oncology starts here! We’re proud to launch touchONCOLOGY Future Leaders 2025—celebrating rising stars touchoncology.com/insight/introd… andrada turcas Ari Rosenberg Elene Mariamidze Eric Lander, MD Minnesota Oncology Jemma Arakelyan, MD, PhD pooja ghatalia Fox Chase Cancer Center Oncologia Brasil

🚨 The latest issue of touchREVIEWS in Oncology & Haematology is here! Explore expert insights on lymphoma, melanoma, lung & biliary cancers, leukaemia, and more. 🧬 Read now: touchoncology.com/journals/touch… #Oncology #Haematology #CancerResearch #MedicalEducation #Lymphoma #Melanoma